Tandem Diabetes Care, Inc. (TNDM)
15.88
-0.28
(-1.73%)
USD |
NASDAQ |
Oct 07, 15:36
Tandem Diabetes Care Net Income (Quarterly) : -21.17M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.17M |
| March 31, 2026 | -20.39M |
| December 31, 2025 | -0.589M |
| September 30, 2025 | -21.16M |
| June 30, 2025 | -52.40M |
| March 31, 2025 | -130.56M |
| December 31, 2024 | 0.755M |
| September 30, 2024 | -23.25M |
| June 30, 2024 | -30.81M |
| March 31, 2024 | -42.72M |
| December 31, 2023 | -30.00M |
| September 30, 2023 | -32.96M |
| June 30, 2023 | -35.78M |
| March 31, 2023 | -123.87M |
| December 31, 2022 | -15.85M |
| September 30, 2022 | -48.97M |
| June 30, 2022 | -15.06M |
| March 31, 2022 | -14.72M |
| December 31, 2021 | 10.81M |
| September 30, 2021 | 5.794M |
| June 30, 2021 | 4.008M |
| March 31, 2021 | -5.044M |
| December 31, 2020 | 17.00M |
| September 30, 2020 | -9.408M |
| June 30, 2020 | -27.11M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.87M |
| December 31, 2019 | 2.652M |
| September 30, 2019 | -2.901M |
| June 30, 2019 | -1.512M |
| March 31, 2019 | -22.99M |
| December 31, 2018 | 3.686M |
| September 30, 2018 | -34.24M |
| June 30, 2018 | -59.36M |
| March 31, 2018 | -32.69M |
| December 31, 2017 | -11.40M |
| September 30, 2017 | -16.04M |
| June 30, 2017 | -21.80M |
| March 31, 2017 | -23.79M |
| December 31, 2016 | -14.82M |
| September 30, 2016 | -29.81M |
| June 30, 2016 | -18.32M |
| March 31, 2016 | -20.48M |
| December 31, 2015 | -12.09M |
| September 30, 2015 | -19.58M |
| June 30, 2015 | -19.53M |
| March 31, 2015 | -21.21M |
| December 31, 2014 | -18.47M |
| September 30, 2014 | -19.90M |
| June 30, 2014 | -19.20M |
| March 31, 2014 | -21.96M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Senseonics Holdings, Inc. | -36.70M |
| Abbott Laboratories | 928.00M |
| Accuray, Inc. | -1.941M |
| DexCom, Inc. | 249.10M |
| Micron Solutions, Inc. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 254.14M |
| Total Expenses (Quarterly) | 275.31M |
| EPS Diluted (Quarterly) | -0.3067 |
| Enterprise Value | 1.407B |
| Gross Profit Margin (Quarterly) | 56.80% |
| Profit Margin (Quarterly) | -8.33% |
| Earnings Yield | -5.83% |
| Normalized Earnings Yield | -5.651 |